Is Medication Assisted Treatment Effective? 5 Powerful Benefits 2025

Why Evidence Proves MAT is the Most Effective Treatment for Opioid Addiction

Is medication assisted treatment effective? Yes, medication-assisted treatment (MAT) is highly effective for treating opioid use disorder. Research consistently shows that MAT reduces overdose deaths by approximately 50%, increases treatment retention rates, and significantly improves long-term recovery outcomes compared to non-medication approaches.

Key Effectiveness Evidence:

• 76% reduction in overdose risk at 3 months with buprenorphine/methadone
• 59% reduction in overdose risk at 12 months
• 52.1% to 20.4% decrease in heroin use after 6 months of treatment
• Improved mental health – anxiety dropped from 49.7% to 23.2%, depression from 54.1% to 23.3%
• Better social outcomes including increased employment and reduced criminal activity

Despite this strong evidence, fewer than half of privately-funded treatment programs offer MAT, and only one-third of patients with opioid dependence actually receive it. This treatment gap leaves millions without access to life-saving care.

The opioid crisis has reached devastating proportions, with one overdose death occurring every 20 minutes in the United States. Over 2 million Americans struggle with opioid use disorder, yet access to evidence-based treatment remains limited by stigma, misconceptions, and systemic barriers.

As Dr. Chad Elkin, founder and Chief Medical Officer of National Addiction Specialists, I’ve dedicated my career to expanding access to evidence-based addiction treatment and have seen how is medication assisted treatment effective in changing lives through comprehensive, patient-centered care. My experience treating thousands of patients confirms what the research shows – MAT saves lives when barriers to access are removed.

Simple guide to is medication assisted treatment effective terms:

• benefits of medication assisted treatment
• buprenorphine medication assisted treatment
• medication assisted treatment online

What Is Medication-Assisted Treatment (MAT) & How It Works

Medication-assisted treatment is an evidence-based approach that combines FDA-approved medications with counseling and behavioral therapies to treat opioid use disorder. Think of it as a “whole-patient” approach – we’re not just addressing the physical dependence, but also the psychological and social aspects of addiction.

MAT works by targeting the same brain receptors that opioids affect, but in a controlled, therapeutic way. When someone uses heroin or prescription opioids, these drugs flood the brain’s reward system, creating intense euphoria followed by devastating withdrawal. MAT medications normalize brain chemistry without producing a dangerous high, allowing patients to function normally while their brain heals.

The World Health Organization considers buprenorphine and methadone “essential medicines” for treating opioid use disorder – putting them in the same category as insulin for diabetes or blood pressure medications for hypertension. This medical recognition reflects decades of research proving MAT’s effectiveness.

Mechanisms Behind MAT

The science behind MAT centers on the brain’s mu-opioid receptors, which are part of the reward pathway that drives addiction. These receptors naturally respond to the body’s own opioids (endorphins), but chronic opioid use hijacks this system.

MAT medications work through three different mechanisms:

Full Agonists (like methadone) fully activate opioid receptors, preventing withdrawal and cravings while blocking the effects of other opioids. They provide steady, long-lasting relief without euphoria when properly dosed.

Partial Agonists (like buprenorphine) partially activate receptors, providing enough stimulation to prevent withdrawal but with a “ceiling effect” that limits overdose risk. This makes them safer while still being highly effective.

Antagonists (like naltrexone) block opioid receptors entirely, preventing any opioid from having an effect. They don’t prevent withdrawal but can prevent relapse once someone is already clean.

FDA-Approved Medications Are Core

The FDA has approved three medications specifically for opioid use disorder:

Methadone has been used since 1947 and remains highly effective. It’s a full opioid agonist that lasts 24-36 hours, making daily dosing practical. However, it can only be dispensed through certified opioid treatment programs (OTPs) due to its overdose potential.

Buprenorphine was first approved in 2002 and revolutionized treatment by allowing office-based prescribing. It’s available alone or combined with naloxone (as Suboxone) to prevent injection misuse. Its partial agonist properties make it much safer than methadone.

Naltrexone comes in both daily oral and monthly injectable forms. The extended-release injection (Vivitrol) is particularly useful for patients who struggle with daily medication adherence, though it requires complete detoxification before starting.

Is Medication Assisted Treatment Effective? The Evidence Speaks

When families ask me “is medication assisted treatment effective?” I understand their skepticism. After watching a loved one struggle with addiction, it’s natural to wonder if any treatment truly works. The good news is that decades of research provide a clear, resounding answer: MAT is not just effective—it’s the most effective treatment we have for opioid use disorder.

The evidence comes from multiple sources that all tell the same story. Clinical trials involving thousands of patients show that people receiving MAT are 4.44 times more likely to stay in treatment compared to those getting counseling alone. They also have 33% fewer positive drug tests and show dramatic reductions in risky behaviors like sharing needles or committing crimes to fund their addiction.

But research numbers only tell part of the story. Real-world programs like Colorado’s rural pilot project show us what happens when communities accept MAT. Researchers followed 1,005 patients who started treatment in underserved counties, and the results were nothing short of remarkable.

After just six months of treatment, heroin use dropped from 52.1% to 20.4%. Even more striking, daily heroin use plummeted from 37.1% to just 5.4%. Prescription opioid misuse also fell significantly, from 22.3% to 11.0%. These aren’t just statistics—they represent real people getting their lives back.

Perhaps most importantly, patients reported dramatic improvements in their mental health. Moderate-to-severe anxiety decreased from 49.7% to 23.2%, while depression fell from 54.1% to 23.3%. This mental health improvement is crucial because untreated anxiety and depression often drive people back to using drugs.

For more comprehensive information about evidence-based approaches, see this scientific research on MAT outcomes from the CDC.

Is Medication Assisted Treatment Effective for Reducing Overdose Deaths?

The overdose prevention evidence is so strong that it’s become the cornerstone argument for expanding MAT access. A comprehensive analysis of insurance claims data for over 40,000 patients found that only buprenorphine and methadone provided significant protection against fatal overdoses.

The numbers are striking: patients on MAT had a 76% reduction in overdose risk at three months and a 59% reduction at twelve months. They also had 32% and 26% fewer serious opioid-related emergency room visits and hospitalizations.

The Sordo meta-analysis, which combined data from multiple studies, confirmed these findings across different populations and treatment settings. Communities that expanded MAT access consistently saw drops in overdose deaths, while areas without adequate treatment continued to see rising mortality rates.

Colorado’s experience provides a perfect real-world example. Opioid overdose deaths dropped from 18.0 to 14.8 per 100,000 people in Pueblo County. In Routt County, the results were even more dramatic—overdose deaths fell from 20.6 per 100,000 to zero between 2017 and 2019.

These mortality benefits aren’t temporary. Long-term studies consistently show that staying on methadone or buprenorphine reduces the risk of death by approximately 50% compared to no treatment. When we combine MAT with naloxone distribution and overdose education, the protective effects become even stronger.

Is Medication Assisted Treatment Effective for Long-Term Recovery?

Recovery means more than just not using drugs—it means rebuilding a meaningful life. Five-year cohort studies reveal that MAT’s benefits extend far beyond overdose prevention into every aspect of a person’s well-being.

Social functioning improves dramatically over time. Patients maintain employment at higher rates, rebuild relationships with family members, and contribute positively to their communities. The Colorado study found that patients reported improved overall health, rising from 53.4% to 68.2% feeling healthy. They also had fewer disability days, dropping from 8.69 to 6.51 days per month.

Quality of life improvements go beyond just stopping drug use. Patients report better physical health, restored relationships, and renewed hope for the future. Many return to school, start new careers, or reconnect with children they’d lost contact with during active addiction.

Relapse prevention becomes more effective the longer patients stay in treatment. Twelve-month retention rates vary from 37% to 91% across different treatment settings, with higher retention consistently linked to better long-term outcomes. This is why we focus so heavily on making treatment accessible and removing barriers that might cause someone to drop out.

The evidence is clear: is medication assisted treatment effective? Absolutely. MAT doesn’t just save lives in the short term—it helps people rebuild meaningful, productive lives over the long haul.

Medication Options Explained: Methadone vs. Buprenorphine vs. Naltrexone

Choosing the right medication is like finding the right key for a lock – what works perfectly for one person might not be the best fit for another. The good news is that we have three excellent FDA-approved options, each with its own strengths and ideal situations.

Think of these medications as different tools in a toolbox. Methadone is like a heavy-duty wrench – powerful and reliable for the toughest jobs. Buprenorphine is more like a versatile multi-tool – safer, more convenient, and works well for most situations. Naltrexone is like a protective shield – it doesn’t fix the immediate problem but prevents future damage.

The pharmacology behind each medication determines how they work in your body. Methadone and buprenorphine both activate opioid receptors (though in different ways), while naltrexone blocks them completely. These differences affect everything from dosing schedules to side effects to cost considerations.

Understanding these differences helps you and your doctor make the best choice for your unique situation. Let’s break down what makes each medication special.

Methadone: Full Agonist Staple

Methadone has been saving lives since 1947, and it remains one of our most powerful tools against severe opioid addiction. As a full agonist, it completely satisfies your brain’s opioid receptors without causing a high when taken as prescribed.

The science behind methadone’s effectiveness is impressive. It stays in your system for 24-36 hours, which means once-daily dosing can keep withdrawal symptoms and cravings at bay all day long. Research consistently shows that doses above 60mg are associated with much better outcomes – staying in treatment longer and using fewer street drugs.

However, methadone comes with strict regulations due to its potency. You can only get it through certified opioid treatment programs (OTPs), which means daily trips to the clinic, at least initially. This daily dispensing requirement can feel restrictive, but it also provides built-in support and monitoring.

The medication requires careful medical oversight because it can interact with other drugs and affect heart rhythm in some people. But for patients with severe, long-standing addiction – especially those who haven’t succeeded with other treatments – methadone often provides the stability needed to rebuild their lives.

Buprenorphine: Office-Based Convenience

Buprenorphine changed everything when it became available for office-based treatment. Suddenly, people could get effective medication for opioid addiction from their regular doctor, without the stigma or inconvenience of daily clinic visits.

As a partial agonist, buprenorphine has a built-in safety feature called the “ceiling effect.” This means that after a certain dose, taking more doesn’t increase the effects – dramatically reducing overdose risk. It’s like having a safety valve that prevents dangerous complications.

Recent policy changes have made buprenorphine even more accessible. The elimination of the X-waiver requirement means any licensed physician can now prescribe it without special training or registration. This has opened doors for thousands of patients who previously couldn’t access treatment.

At National Addiction Specialists, we’ve seen how proper buprenorphine dosing makes all the difference. Many patients who thought they “failed” on buprenorphine were simply under-dosed. Research shows that doses of 16mg or higher lead to 1.82 times better retention rates and significantly fewer positive drug tests.

For detailed information about starting treatment, this scientific research on buprenorphine initiation provides valuable insights for both patients and providers.

The convenience factor can’t be overstated. Patients can pick up their prescription at a regular pharmacy, maintain their privacy, and integrate treatment into their normal routine. This accessibility is part of why is medication assisted treatment effective – when treatment fits into your life, you’re more likely to stick with it.

Naltrexone: Antagonist & Relapse Shield

Extended-release naltrexone (Vivitrol) takes a completely different approach. Instead of replacing opioids, it blocks them entirely. Think of it as installing a security system that prevents opioids from having any effect at all.

The monthly injection format addresses one of addiction treatment’s biggest challenges – medication adherence. You can’t forget to take your dose or decide to skip it during a moment of weakness. Once you get the shot, you’re protected for 30 days.

This makes naltrexone particularly valuable for certain situations. People leaving jail or prison often choose it because there’s no stigma about taking an opioid medication. Highly motivated patients who want to avoid any opioid-based treatment also find it appealing.

However, naltrexone has strict post-detox requirements. You must be completely opioid-free for 7-14 days before starting, or you’ll experience precipitated withdrawal – which is as unpleasant as it sounds. This requirement makes it challenging for many patients who struggle with the detox process.

The research shows mixed results for retention rates with naltrexone. While it can be highly effective for the right patient, studies consistently show lower retention rates compared to buprenorphine or methadone. Success often depends on having strong external support systems and high internal motivation.

Cost can also be a barrier, as the monthly injection is more expensive than daily oral medications. However, many insurance plans, including Medicaid, cover it when medically appropriate.

Make an Appointment to Treat Addiction
Please don’t hesitate. Make an appointment today.

Beyond Medication: Counseling, Behavioral Therapies & Holistic Supports

Here’s something many people don’t realize: is medication assisted treatment effective reaches its true potential only when paired with comprehensive counseling and behavioral support. The “assisted” part of MAT isn’t just about the medication – it’s about wrapping patients in a complete system of care that addresses every aspect of addiction.

Think of it this way: if addiction were a broken leg, medication would be the cast that stabilizes the bone. But you’d also need physical therapy, pain management, and lifestyle changes to fully heal. Recovery works the same way.

Cognitive-behavioral therapy (CBT) forms the backbone of most MAT programs. This approach helps patients recognize triggers, develop healthy coping strategies, and change thought patterns that lead to drug use. It’s like rewiring the brain’s response to stress and cravings.

Contingency management takes a different but powerful approach by providing real rewards for positive behaviors. When patients submit clean drug tests or attend counseling sessions, they earn vouchers or prizes. This might sound simple, but research shows it dramatically improves both treatment retention and outcomes.

Peer support connects patients with others who’ve walked the same path. There’s something uniquely powerful about hearing from someone who truly understands your struggles because they’ve lived them too.

At National Addiction Specialists, we’ve acceptd tele-counseling as a game-changer for our patients in Tennessee and Virginia. No more missing therapy sessions because of work conflicts or transportation issues. Patients can access their counselor from home, maintaining privacy while building the therapeutic relationships essential for lasting recovery.

Federal regulations under 42 CFR 8.12 actually require that buprenorphine prescribers ensure patients have access to counseling and psychosocial services. This isn’t bureaucratic red tape – it’s recognition that medication alone, while life-saving, isn’t enough for most people.

Integrating Care Improves Outcomes

The reality is that addiction rarely travels alone. Most patients struggle with co-occurring disorders like depression, anxiety, or trauma. Treating only the addiction while ignoring these underlying issues is like trying to fix a leaky roof during a thunderstorm – you might patch one hole, but others will keep causing problems.

HIV risk reduction becomes natural when comprehensive MAT programs address injection drug use through needle exchange, safe injection education, and regular testing. Studies consistently show that MAT patients engage in far fewer risky behaviors.

Family therapy often proves crucial for healing relationships damaged by years of addiction. When families understand addiction as a medical condition rather than a moral failing, they become powerful allies in recovery rather than sources of shame and conflict.

The integration of medical and behavioral care creates something greater than the sum of its parts. Patients receiving comprehensive MAT don’t just stop using opioids – they rebuild their lives, repair relationships, and refind hope for the future.

Make an Appointment to Treat Addiction
Please don’t hesitate. Make an appointment today.

Benefits, Risks & Common Misconceptions About MAT

When families ask me “is medication assisted treatment effective?” I often share the story of Sarah, a patient who went from daily heroin use to completing nursing school while on buprenorphine treatment. Her change illustrates the profound benefits MAT can bring – not just stopping drug use, but rebuilding entire lives.

The research backs up what we see every day in our practice. MAT patients experience dramatic reductions in criminal activity, with arrest rates dropping by 40-60% after starting treatment. This isn’t just about following the law – it’s about people having the mental clarity and stability to make better choices.

Employment outcomes improve significantly too. Studies show that MAT patients are twice as likely to maintain steady jobs compared to those receiving behavioral therapy alone. When your brain isn’t consumed by cravings and withdrawal, you can actually focus on work, relationships, and rebuilding your life.

Perhaps most importantly, MAT prevents the spread of infectious diseases like HIV and hepatitis C. When people stop injecting drugs or sharing needles, transmission rates plummet. This protects not just the individual patient, but their partners and the broader community.

Family relationships heal when someone is stable on MAT. Parents regain custody of their children, marriages are repaired, and families can finally start planning for the future instead of just surviving each day.

Addressing Side Effects & Safety

I always tell patients that every medication has side effects, and MAT medications are no exception. The good news is that most side effects are manageable and often improve over time.

Constipation is by far the most common complaint with methadone and buprenorphine. It affects nearly every patient to some degree. We recommend increased fiber, plenty of water, and sometimes stool softeners. It’s inconvenient, but it’s not dangerous.

Drowsiness or fatigue often occurs in the first few weeks as your body adjusts. This usually improves as we find the right dose. We work with patients to time their medication so it doesn’t interfere with work or driving.

Sleep disturbances can be tricky. Some patients feel more alert at bedtime, while others sleep better than they have in years. We often adjust timing or explore sleep hygiene strategies.

The serious side effects require careful monitoring but are quite rare. Cardiac issues are our biggest concern with methadone, which is why we do periodic EKGs. Respiratory depression can occur, especially when people mix MAT medications with alcohol or benzodiazepines – which is why we strongly advise against combining substances.

Precipitated withdrawal is something we’re very careful to avoid. This happens when someone takes naltrexone too soon after using opioids. It’s extremely uncomfortable but not dangerous, and it’s completely preventable with proper timing.

Dispelling “One Addiction for Another”

The most harmful myth I encounter is that MAT just substitutes “one addiction for another.” This misconception keeps people from seeking life-saving treatment and causes unnecessary guilt for those already in recovery.

Let me be clear: addiction and physical dependence are completely different things. Addiction involves compulsive use despite harmful consequences, loss of control, and continued use even when you desperately want to stop. Physical dependence simply means your body has adapted to a substance – something that happens with blood pressure medications, antidepressants, and many other legitimate medicines.

When someone takes buprenorphine as prescribed, they’re not “getting high” or engaging in addictive behavior. They’re taking medicine that allows them to function normally – to work, parent, and participate in life. The medication eliminates cravings and withdrawal without producing euphoria.

Think of it this way: we don’t say diabetics are “addicted” to insulin, even though they depend on it to live. MAT medications serve the same purpose for people with opioid use disorder – they’re medical treatment for a medical condition.

The outcomes speak for themselves. People on MAT have better relationships, stable employment, improved health, and dramatically lower death rates. These are the hallmarks of recovery, not addiction.

At National Addiction Specialists, we’ve seen thousands of patients transform their lives through MAT. The evidence is overwhelming, the benefits are real, and the myths are just that – myths that prevent people from getting the help they need.

Make an Appointment to Treat Addiction
Please don’t hesitate. Make an appointment today.

Access & Future Directions: Breaking Barriers & Boosting Retention

While we know is medication assisted treatment effective based on overwhelming research, the sad reality is that millions of Americans still can’t access this life-saving care. It’s frustrating when you consider that we have the tools to save lives, but systemic barriers keep getting in the way.

The numbers paint a stark picture. 30 million Americans live in counties without any providers who can prescribe buprenorphine. That’s like having effective cancer treatment but no oncologists within driving distance. Rural communities are hit especially hard – some patients drive hours just to get their medication.

Even where providers exist, many treatment programs haven’t caught up with the science. Only 23% of publicly funded programs offer FDA-approved medications. That means three out of four programs are still operating without the most effective tools we have.

Insurance creates another roadblock. Prior authorization requirements can delay treatment for weeks – time that could mean the difference between life and death for someone struggling with overdose risk. Some insurance plans require people to “fail” at other treatments first, which is like requiring someone with diabetes to get sicker before allowing insulin.

Recent policy changes offer hope. The elimination of X-waiver requirements means any physician can now prescribe buprenorphine without special training or patient limits. Telehealth expansion during COVID-19 showed how technology can bridge geographic gaps. States are also requiring Medicaid programs to cover MAT services more comprehensively.

Criminal justice settings are increasingly recognizing that is medication assisted treatment effective for reducing recidivism. Programs that continue MAT for incarcerated individuals and connect them to treatment upon release see dramatic improvements in outcomes.

Improving Retention in Care

Staying in treatment long enough to see benefits remains a challenge. Some programs report retention rates as low as 37%, while others achieve over 90%. The difference often comes down to how patient-centered the approach is.

Flexible scheduling makes a huge difference. When someone has to choose between keeping their job and getting their medication, they’re in an impossible position. Programs that offer evening hours, weekend dosing, or take-home privileges see much better retention.

Trauma-informed care recognizes that many people with addiction have histories of abuse, neglect, or other trauma. Staff trained to understand trauma create safer environments where patients feel respected rather than judged.

Addressing basic needs like housing, food security, and transportation removes barriers that can derail recovery. It’s hard to focus on sobriety when you don’t know where you’ll sleep tonight.

The Colorado pilot program found that maintaining an “open-door policy” was crucial. Instead of discharging patients who missed appointments, successful programs kept them on registries and actively reached out when they were ready to return. This approach recognizes that recovery isn’t always linear.

Peer support from people who’ve been through similar experiences provides hope and practical guidance. Seeing someone who was once where you are now thriving in recovery is incredibly powerful.

Finding Help Today

If you or someone you love needs MAT, several resources can help you find care today. The SAMHSA Treatment Locator at FindTreatment.gov provides comprehensive listings of treatment programs nationwide. You can search by location, insurance type, and specific services offered.

For buprenorphine specifically, SAMHSA maintains a practitioner locator that helps find prescribing physicians in your area. The National Helpline (1-800-662-HELP) offers 24/7 support and can provide referrals to local resources.

At National Addiction Specialists, we’ve designed our telemedicine approach specifically to eliminate many traditional barriers. Patients throughout Tennessee and Virginia can access comprehensive MAT services from the comfort and privacy of their own homes. Our services include initial assessments, medication management, integrated counseling, and coordination with local healthcare providers.

We accept Medicaid and Medicare, removing financial barriers that keep too many people from getting help. Our team understands that seeking treatment takes courage, and we work hard to make the process as comfortable and convenient as possible.

Make an Appointment to Treat Addiction
Please don’t hesitate. Make an appointment today.
Start your recovery journey

The future of addiction treatment lies in expanding access through technology, reducing regulatory barriers, and changing attitudes about addiction as a medical condition. Every person who gets connected to effective treatment represents not just a life saved, but families healed and communities strengthened.

Conclusion

The overwhelming mountain of evidence leaves no room for doubt: is medication assisted treatment effective? The answer is a resounding yes. MAT doesn’t just work – it transforms lives in ways that seemed impossible just decades ago.

When we look at the numbers, they tell a powerful story. 76% reduction in overdose risk. 50% decrease in mortality rates. Thousands of families reunited. Careers rebuilt. Hope restored where there was once only desperation.

Yet here’s what breaks my heart as an addiction medicine physician: despite this incredible evidence, too many people still can’t access the treatment they desperately need. Stigma whispers lies about “trading one addiction for another.” Geographic barriers leave entire communities without options. Insurance companies create hoops that delay life-saving care.

This has to change. Every day we delay expanding access, we lose people who could have been saved.

At National Addiction Specialists, we’ve made it our mission to tear down these barriers. Through our telemedicine platform, we bring evidence-based MAT directly to your living room. No more driving hours to the nearest clinic. No more missing work for daily visits. No more shame in crowded waiting rooms.

I’ve watched patients transform their lives from their kitchen tables. Parents who thought they’d never see their children again now tuck them in every night. People who couldn’t hold a job are now mentoring others in recovery. The grandmother who was stealing from her grandchildren’s college fund is now helping save for their futures.

Recovery isn’t just possible – it’s happening every single day. The medications work. The counseling helps. The support makes all the difference. What matters most is taking that first brave step forward.

Make an Appointment to Treat Addiction
Please don’t hesitate. Make an appointment today.
Start your recovery journey

If you’re reading this and struggling with opioid use disorder, know this: you’re not broken. You’re not weak. You have a medical condition that responds beautifully to medical treatment. Recovery is waiting for you, and it’s closer than you think.

Through our telemedicine services in Tennessee and Virginia, we can begin your treatment as soon as today. We’ll provide the medications that stop cravings and withdrawal. We’ll connect you with counselors who understand your journey. We’ll walk alongside you every step of the way back to the life you deserve.

The question isn’t whether MAT works anymore – the research has settled that debate. The only question that matters now is: are you ready to let it work for you?

More info about teleMAT services

Medically Reviewed By

Chad D. Elkin, MD, FASAM, ABIM, ABPM

Chad D. Elkin, MD, FASAM, ABIM, ABPM, is double board-certified in both Internal Medicine and Addiction Medicine and is a Fellow of the American Society of Addiction Medicine (ASAM). His professional interests focus on social determinants of health, addiction medicine, public education concerning the opioid epidemic, public speaking engagements, and addiction medicine legislative advocacy at the state and national level . He is heavily involved with ASAM with both national and state roles including activity on the Practice Management and Regulatory Affairs Committee (PMRAC), State Advocacy and Legislative Affairs Committee (SALC), and is the Legislative Chairman and President-elect for the Tennessee chapter of ASAM.

Suboxone® and Subutex® are a registered trademark of Indivior UK Limited. Any mention and reference of Suboxone® and Subutex® in this website is for informational purposes only and is not an endorsement or sponsorship by Indivior UK Limited.